Improved aqueous solubility of crystalline astaxanthin (3,3′-dihydroxy-β, β-carotene-4,4′-dione) by Captisol® (sulfobutyl ether β-cyclodextrin)

Journal of Pharmaceutical Sciences

Volumn 92, Issue 4, 2003, Pages 922-926

  Lockwood, Samuel F ^a   O'Malley, Sean ^a   Mosher, Gerold L ^b  

^a HAWAII BIOTECH INC   (United States)

^b CyDex LC   (United States)

Author keywords

3,3 dihydroxy , carotene 4,4 dione; Astaxanthin; Captisol ; Carotenoids; Water solubility; cyclodextrin

Indexed keywords

ASTAXANTHIN; BETA CYCLODEXTRIN SULFOBUTYL ETHER; CAROTENOID;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; CRYSTAL; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY;

EID: 0037380545     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10359     Document Type: Article

References (18)

1. Britton G. 1995. Structure and properties of carotenoids in relation to function. FASEB J 9:1551-1558.
2. Torrissen OJ, Hardy RW, Shearer KD. 1989. Pigmentation of salmonids - Carotenoid deposition and metabolism. CRC Crit Rev Aquat Sci 1:209-225.
3. Torrissen OJ, Christiansen R. 1995. Requirements for carotenoids in fish diets. J Appl Ichthyol 11:225-230.
4. Foss P, Renstrøm B, Liaaen-Jensen S. 1987. Natural occurrence of enantiomeric and meso astaxanthin. 7. Crustaceans including zooplankton. Comp Biochem Physiol B Comp Biochem 86:313-314.
5. Turujman SA, Warner WG, Wei RR, Albert RH. 1997. Rapid liquid chromatographic method to distinguish wild salmon from aquacultured salmon fed synthetic astaxanthin. J AOAC Int 80:622-632.
6. Khachik F, Beecher GR, Goli MB, Lusby WR, Daitch CE. 1992. Separation and quantification of carotenoids in human plasma. In Packer L, editor. Carotenoids. Part A. Chemistry, separation, quantitation, and antioxidation. San Diego: Academic Press, Inc., p 205-219.
7. Bikadi Z, Zsila F, Deli J, Mady G, Simonyi M. 2002. The supramolecular structure of self-assembly formed by capsanthin derivatives. Enantiomer 7:67-76.
8. Strege MA. 1998. Hydrophilic interaction chromatography-electrospray mass spectrometry analysis of polar compounds for natural product drug discovery. Anal Chem 70:2439-2445.
9. Mele A, Selva A. 1997. Letter: A study by mass spectrometry on the volatility of trans-beta-carotene after complexation with beta-cyclodextrin in water. Eur Mass Spectrom 3:161-163.
10. Jyonouchi H, Hill R, Tomita Y, Good R. 1991. Studies of immunomodulating actions of carotenoids. I. Effects of beta-carotene and astaxanthin on murine lymphocyte functions and cell surface marker expression in in vitro culture system. Nutr Cancer 16:93-105.
11. Kurashige M, Okimasu E, Inoue M, Utsumi K. 1990. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR 22:27-38.
12. Mortensen A, Skibsted LH, Truscott TG. 2001. The interaction of dietary carotenoids with radical species. Arch Biochem Biophys 385:13-19.
13. Nakagawa K, Kang S, Park D, Handelman G, Miyazawa T. 1997. Inhibition of beta-carotene and astaxanthin of NADPH-dependent microsomal phospholipid peroxidation. J Nutr Sci Vitaminol (Tokyo) 43:345-355.
14. Lancrajan I, Diehl HA, Socaciu C, Engelke M, Zorn-Kruppa M. 2001. Carotenoid incorporation into natural membranes from artificial carriers: Liposomes and beta-cyclodextrins. Chem Phys Lipids 112:1-10.
15. Bjerkeng B, Hamre K, Hatlen B, Wathne E. 1999. Astaxanthin deposition in fillets of Atlantic salmon Salmo salar L. fed two dietary levels of astaxanthin in combination with three levels of α-tocopheryl acetate. Aquac Res 30:637-646.
16. Britton G, Liaaen-Jensen S, Pfander H. 1995. Carotenoids, Vol. I: Isolation and analysis. Basel, Switzerland: Birkhauser Verlag.
17. Saarinen-Savolainen P, Jarvinen T, Araki-Sasaki K, Watanabe H, Urtti A. 1998. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm Res 15:1275-1280.
18. Tötterman AM, Schipper NGM, Thompson DO, Mannermaa J-P, Kaukonen AM. 1997. Intestinal safety of water-soluble B-cyclodextrins in paediatric oral solutions of spironolactone: Effects on human intestinal epithelial Caco-2 cells. J Pharm Pharmacol 49:43-48.